Skip to main content
Log in

Changes in Motor Activity and the Sleep–Waking Cycle in an MPTP Model of Parkinson’s Disease in Mice

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

Mice with previously implanted electrodes for recording the cortical electroencephalogram and electromyograms underwent all-day baseline videopolysomnography with a 12/12 light cycle, after which animals received doses of 24 or 48 mg/kg of the neurotoxin precursor MPTP (1-methyl-4-phenyl-1.2.3.7-tetrahydropyridine) or physiological saline (controls) and recording was continued for 14 days. At the end of the experiments, morphological monitoring of the extent of lesions to the dopaminergic system was performed. Increases in motor activity and the total duration of waking during the dark part of the night were seen after administration of MPTP, as compared with controls. These changes were accompanied by decreases in the durations of rapid and (at the level of a tendency) slow-wave sleep. These changes were apparent by recording day 7 and were significant by day 14; they were more marked after treatment at a dose of 48 mg/kg than after the smaller dose. No changes were seen during the light period of the day. Morphological monitoring demonstrated a 70% reduction in the number of dopamine-containing neurons in the compact zone of the substantia nigra after administration of MPTP (48 mg/kg) and a 35% drop after MPTP (24 mg/kg).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. V. M. Koval’zon, “The brain and sleep: from neurons to molecules,” Zh. Vyssh. Nerv. Deyat., 73, No. 1, 48–70 (2013).

    Google Scholar 

  2. V. M. Koval’zon, “The role of the histaminergic system of the brain in regulating the sleep–waking cycle,” Fiziol. Cheloveka, 39, No. 7, 13–23 (2013).

    PubMed  Google Scholar 

  3. V. M. Koval’zon, “Central mechanisms of regulation of the sleep–waking cycle,” Fiziol. Cheloveka, 37, No. 4, 124–134 (2011).

    PubMed  Google Scholar 

  4. V. M. Koval’zon and I. M. Zavalko, “The sleep–waking cycle and Parkinson’s disease,” Neirokhimiya, 30, No. 3, 193–207 (2013).

  5. Yu. F. Pastukhov, “Changes in the characteristics of paradoxical sleep– an early sign of parkinsonism,” Zh. Vyssh. Nerv. Deyat., 73, No. 1, 75–85 (2013).

    Google Scholar 

  6. O. Sacks, Awakenings [Russian translation], Astrel, Moscow (2013).

    Google Scholar 

  7. C. Blanco-Centurion, D. Gerashchenko, and P. J. Shiromani, “Effects of saporin-induced lesions of three arousal populations on daily levels of sleep and wake,” J. Neurosci., 27, No. 51, 14041–14048 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. K. Fifel, O. Dkhissi-Benyahya, and H. M. Cooper, “Lack of longterm changes in circadian, locomotor, and cognitive functions in acute and chronic MPTP (1.2.3.7-tetrahydropyridine) mouse models of Parkinson’s disease,” Chronobiol. Int., 30, No. 7, 741–755 (2013).

    Article  CAS  PubMed  Google Scholar 

  9. A. Iranzo, “Sleep-wake changes in the premotor stage of Parkinson disease,” J. Neurol. Sci., 310, 283–285 (2011).

    Article  PubMed  Google Scholar 

  10. C. Laloux, P. Derambure, J.-M. Jacquesson, et al., “The effects of serotoninergic, noradrenergic, cholinergic and dopaminergic drugs on vigilance states in MPTP-treated mice,” Brain Res., 117, 79–87 (2007).

    Article  Google Scholar 

  11. C. Laloux, P. Derambure, A. Kreisler, et al., “MPTP-treated mice: long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations,” Exp. Brain Res., 187, 735–742 (2008).

    Google Scholar 

  12. W. Le, P. Sayana, and J. Jankovic, “Animal models of Parkinson’s disease: A gateway to therapeutics?” Neurotherapeutics, 11, 92–110 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. M. S. M. Lima, “Sleep disturbances in Parkinson’s disease: The contribution of dopamine in REM sleep regulation,” Sleep Med. Rev., 17, No. 5, 377–375 (2012).

    Google Scholar 

  14. C. Monaca, C. Laloux, J.-M. Jacquesson, et al., “Vigilance states in a parkinsonian model, the MPTP mouse,” Eur. J. Neurosci., 20, No. 9, 2474–2478 (2004).

    Article  PubMed  Google Scholar 

  15. J. Peever, P.-H. Luppi, and J. Montplaisir, “Breakdown in REM sleep circuitry underlies REM sleep behavior disorder,” Trends Neurosci., 37, No. 5, 279–288 (2014).

    Article  PubMed  Google Scholar 

  16. I. Shpirer, A. Miniovitz, C. Klein, et al., “Excessive daytime sleepiness in patients with Parkinson’s disease: A polysomnography study,” Mov. Disord., 21, No. 9, 1432–1438 (2007).

    Article  Google Scholar 

  17. M. V. Ugrumov, V. G. Khaindrava, E. A. Kozina, et al., “Modeling of presymptomatic and symptomatic stages of parkinsonism in mice,” Neuroscience, 181, 175–188 (2011).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. M. Koval’zon.

Additional information

Translated from Rossiiskii Fiziologicheskii Zhurnal imeni I. M. Sechenova, Vol. 100, No. 11, pp. 1252–1260, November, 2014.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Manolov, A.I., Dolgikh, V.V., Ukraintseva, Y.V. et al. Changes in Motor Activity and the Sleep–Waking Cycle in an MPTP Model of Parkinson’s Disease in Mice. Neurosci Behav Physi 46, 467–471 (2016). https://doi.org/10.1007/s11055-016-0259-0

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-016-0259-0

Keywords

Navigation